BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Xeroderma Pigmentosum Group D Protein

Below is an extended Xeroderma Pigmentosum Group D Protein research listing. Click here to return to the Xeroderma Pigmentosum Group D Protein main in depth entry.

Recent Publications on Xeroderma Pigmentosum Group D Protein:

The investigation of DNA repair polymorphisms with histopathological characteristics and hormone receptors in a group of Brazilian women with breast cancer. 9th October, 2008
Departamento de Pathologia, Universidade Federal de Santa Catarina,
Ferroplasma acidarmanus RPA2 Facilitates Efficient Unwinding of Forked DNA Substrates by Monomers of FacXPD Helicase.
The strand-separation activity that is important for many cellular DNA...
Direct Link
20th September, 2008
Department of Biochemistry, University of Illinois at Urbana-Champaign,
Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans.
Few studies on the association between nucleotide excision repair (NER)...
Direct Link
17th September, 2008
Department of Epidemiology and Biostatistics, University of California,
Genotypes and haplotypes of ERCC1 and ERCC2/XPD genes predict levels of benzo[a]pyrene diol epoxide-induced DNA adducts in cultured primary lymphocytes from healthy individuals: a genotype-phenotype correlation analysis.
Benzo[a]pyrene diol epoxide (BPDE)-induced DNA adducts are a risk factor...
Direct Link
5th September, 2008
Department of Epidemiology, The University of Texas MD Anderson Cancer
ERCC1 and ERCC2 polymorphisms and risk of idiopathic azoospermia in a Chinese population. 22nd August, 2008
Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing
The Gln/Gln genotype of XPD codon 751 as a genetic marker for melanoma risk and Lys/Gln as an important predictor for melanoma progression: a case control study in the Swedish population. 22nd August, 2008
Division of Dermatology, Department of Experimental and Clinical Medicine,
Homeostatic imbalance between apoptosis and cell renewal in the liver of premature aging Xpd mice.
Unrepaired or misrepaired DNA damage has been implicated as a causal...
Direct Link
21st August, 2008
Department of Medicine, Albert Einstein College of Medicine, Bronx, New
Cytogenetic effects induced by Prestige oil on human populations: the role of polymorphisms in genes involved in metabolism and DNA repair.
The spill from the oil tanker Prestige (NW Spain, November 2002) was...
Direct Link
20th August, 2008
Psychobiology Department, University of A Coruna, Edificio de Servicios
Crystal structure of the FeS cluster-containing nucleotide excision repair helicase XPD.
DNA damage recognition by the nucleotide excision repair pathway requires...
Direct Link
12th August, 2008
Rudolf Virchow Center for Experimental Biomedicine, Institute for
DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort. 30th July, 2008
University Clermont 1, Clermont-Ferrand Cedex, France.
MAD2 interacts with DNA repair proteins and negatively regulates DNA damage repair.
MAD2 (mitotic arrest deficient 2) is a key regulator of mitosis. Recently,...
Direct Link
26th July, 2008
Department of Anatomy, Cancer Biology Group, Faculty of Medicine, The
Genetic polymorphisms in the DNA repair enzyme ERCC2 and breast tumour risk in a Chinese population. 23rd July, 2008
Department of Breast Surgery, Breast Cancer Institute, Cancer
Biological tools revamp disease classification.
DNA repair systems enable our cells to respond to carcinogens and...
Direct Link
17th July, 2008
Structure of the DNA repair helicase XPD.
The XPD helicase (Rad3 in Saccharomyces cerevisiae) is a component of...
Direct Link
17th June, 2008
Centre for Biomolecular Sciences, University of St. Andrews, North Haugh,
XPD helicase structures and activities: insights into the cancer and aging phenotypes from XPD mutations.
Mutations in XPD helicase, required for nucleotide excision repair (NER)...
Direct Link
17th June, 2008
Department of Molecular Biology, Skaggs Institute of Chemical Biology, The
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional